Long-term protection of mice from Lyme disease by vaccination with OspA

E. Fikrig, Stephen W Barthold, F. S. Kantor, R. A. Flavell

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


Mice vaccinated with recombinant outer surface protein A (OspA) have been shown to be protected from infection with Borrelia burgdorferi, the agent of Lyme disease, when sacrificed 14 days after challenge with an intradermal inoculum of the spirochete. To determine whether infection was not merely delayed and that protection was long-lasting, we sacrificed vaccinated mice 60, 120, and 180 days after challenge; and to determine whether vaccinated mice retained their immune state over long periods, we challenged mice with B. burgdorferi 60, 90, 120, and 150 days after vaccination. The results of both groups of experiments show that the mice remained free from infection and disease and extend the usefulness of OspA as a vaccine candidate for Lyme borreliosis.

Original languageEnglish (US)
Pages (from-to)773-777
Number of pages5
JournalInfection and Immunity
Issue number3
StatePublished - 1992
Externally publishedYes

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Long-term protection of mice from Lyme disease by vaccination with OspA'. Together they form a unique fingerprint.

Cite this